Tetra Bio-Pharma and Ovensa Will Engage in a Collaboration to Tackle Brain Cancer
Tetra Bio-Pharma Inc. today announced that it has entered into a collaboration agreement with Ovensa Inc. to evaluate TRIOZANTM, a proprietary nanomedicine platform for targeted delivery of cannabinoids to brain tumor cells.